U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07866989) titled 'Nebulized Verapamil in COPD Exacerbations' on Oct. 01.
Brief Summary: This clinical trial evaluated whether adding nebulized verapamil to conventional treatment could improve oxygenation and clinical status in patients hospitalized with an acute exacerbation of chronic obstructive pulmonary disease (COPD).
A total of 60 participants were randomly assigned to two groups. One group received nebulized verapamil in addition to conventional treatment, while the other group received conventional treatment alone. Nebulized verapamil was given at a dose of 10 mg twice daily for three consecutive days. The study assessed changes in oxygenat...